Reverse transcriptase mutations in sequential HIV‐1 isolates in a patient with AIDS

A. D. Gurusinghe, S. A. Land, C. Birch, C. McGavin, D. J. Hooker, G. Tachedjian, R. Doherty, N. J. Deacon

Research output: Contribution to journalArticleResearchpeer-review

20 Citations (Scopus)

Abstract

Sequential human immunodeficiency virus type 1 (HIV‐1) isolates were obtained over a 29‐month period from a person before, during, and after AZT therapy. DNA sequence analysis of polymerase chain‐amplified reverse‐transcriptase gene showed a gradual accumulation of mutations to peak resistance (lC50 2.13 μM AZT) in association with mutations at codons 44, 210, and 369, as well as at 41, 67, 70, and 215. Eight months after cessation of AZT therapy, when an HIV‐1 isolate from the patient was again sensitive to AZT, these mutations had all returned to the pretherapy sequence. © 1995 Wiley‐Liss, Inc.

Original languageEnglish
Pages (from-to)238-243
Number of pages6
JournalJournal of Medical Virology
Volume46
Issue number3
DOIs
Publication statusPublished - 1 Jan 1995

Keywords

  • AZT
  • HIV‐1
  • mutations
  • resistance
  • reverse
  • transcriptase

Cite this

Gurusinghe, A. D., Land, S. A., Birch, C., McGavin, C., Hooker, D. J., Tachedjian, G., ... Deacon, N. J. (1995). Reverse transcriptase mutations in sequential HIV‐1 isolates in a patient with AIDS. Journal of Medical Virology, 46(3), 238-243. https://doi.org/10.1002/jmv.1890460312
Gurusinghe, A. D. ; Land, S. A. ; Birch, C. ; McGavin, C. ; Hooker, D. J. ; Tachedjian, G. ; Doherty, R. ; Deacon, N. J. / Reverse transcriptase mutations in sequential HIV‐1 isolates in a patient with AIDS. In: Journal of Medical Virology. 1995 ; Vol. 46, No. 3. pp. 238-243.
@article{4e0b513efa36439f8dd83e9da10ce5a8,
title = "Reverse transcriptase mutations in sequential HIV‐1 isolates in a patient with AIDS",
abstract = "Sequential human immunodeficiency virus type 1 (HIV‐1) isolates were obtained over a 29‐month period from a person before, during, and after AZT therapy. DNA sequence analysis of polymerase chain‐amplified reverse‐transcriptase gene showed a gradual accumulation of mutations to peak resistance (lC50 2.13 μM AZT) in association with mutations at codons 44, 210, and 369, as well as at 41, 67, 70, and 215. Eight months after cessation of AZT therapy, when an HIV‐1 isolate from the patient was again sensitive to AZT, these mutations had all returned to the pretherapy sequence. {\circledC} 1995 Wiley‐Liss, Inc.",
keywords = "AZT, HIV‐1, mutations, resistance, reverse, transcriptase",
author = "Gurusinghe, {A. D.} and Land, {S. A.} and C. Birch and C. McGavin and Hooker, {D. J.} and G. Tachedjian and R. Doherty and Deacon, {N. J.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1002/jmv.1890460312",
language = "English",
volume = "46",
pages = "238--243",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Blackwell",
number = "3",

}

Reverse transcriptase mutations in sequential HIV‐1 isolates in a patient with AIDS. / Gurusinghe, A. D.; Land, S. A.; Birch, C.; McGavin, C.; Hooker, D. J.; Tachedjian, G.; Doherty, R.; Deacon, N. J.

In: Journal of Medical Virology, Vol. 46, No. 3, 01.01.1995, p. 238-243.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Reverse transcriptase mutations in sequential HIV‐1 isolates in a patient with AIDS

AU - Gurusinghe, A. D.

AU - Land, S. A.

AU - Birch, C.

AU - McGavin, C.

AU - Hooker, D. J.

AU - Tachedjian, G.

AU - Doherty, R.

AU - Deacon, N. J.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Sequential human immunodeficiency virus type 1 (HIV‐1) isolates were obtained over a 29‐month period from a person before, during, and after AZT therapy. DNA sequence analysis of polymerase chain‐amplified reverse‐transcriptase gene showed a gradual accumulation of mutations to peak resistance (lC50 2.13 μM AZT) in association with mutations at codons 44, 210, and 369, as well as at 41, 67, 70, and 215. Eight months after cessation of AZT therapy, when an HIV‐1 isolate from the patient was again sensitive to AZT, these mutations had all returned to the pretherapy sequence. © 1995 Wiley‐Liss, Inc.

AB - Sequential human immunodeficiency virus type 1 (HIV‐1) isolates were obtained over a 29‐month period from a person before, during, and after AZT therapy. DNA sequence analysis of polymerase chain‐amplified reverse‐transcriptase gene showed a gradual accumulation of mutations to peak resistance (lC50 2.13 μM AZT) in association with mutations at codons 44, 210, and 369, as well as at 41, 67, 70, and 215. Eight months after cessation of AZT therapy, when an HIV‐1 isolate from the patient was again sensitive to AZT, these mutations had all returned to the pretherapy sequence. © 1995 Wiley‐Liss, Inc.

KW - AZT

KW - HIV‐1

KW - mutations

KW - resistance

KW - reverse

KW - transcriptase

UR - http://www.scopus.com/inward/record.url?scp=0028997461&partnerID=8YFLogxK

U2 - 10.1002/jmv.1890460312

DO - 10.1002/jmv.1890460312

M3 - Article

VL - 46

SP - 238

EP - 243

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 3

ER -